DAVID L MANZO
Allopathic & Osteopathic Physicians|Ophthalmology ROYAL OAK, MI NPI 1386648103
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology MI Amgen Inc. All categories
General Payments — all program years on this page
$2,738.95
- Category: General Payments
- Program years: PY2018–2024
- Record count: 76
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $477.19 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $477.19 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $174.93 | 3 |
| Alcon Laboratories Inc | $153.98 | 2 |
| Oyster Point Pharma, Inc. | $110.70 | 1 |
| Dompe US, Inc. | $19.09 | 1 |
| Tarsus Pharmaceuticals, Inc. | $18.49 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1110669427 | Alcon Vision LLC | $24.20 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110669429 | Alcon Vision LLC | $129.78 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111643312 | Amgen Inc. | $23.62 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111643314 | Amgen Inc. | $25.31 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111643316 | Amgen Inc. | $126.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139114825 | Tarsus Pharmaceuticals, Inc. | $18.49 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147432437 | Oyster Point Pharma, Inc. | $110.70 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151401428 | Dompe US, Inc. | $19.09 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.